The ExoDx Prostate(IntelliScore) take a look at analyzes urine exosomes to offer a threat evaluation for high-grade prostate most cancers. This genomic take a look at helps clinicians decide whether or not a affected person presenting for an preliminary prostate biopsy is at excessive threat for aggressive illness. A damaging take a look at end result might enable some sufferers to securely keep away from an preliminary biopsy. A constructive take a look at end result can present further info to assist a biopsy choice and information additional administration.
This non-invasive strategy provides a major development in prostate most cancers diagnostics. It helps cut back pointless biopsies, minimizing potential problems and affected person anxiousness related to the process. By figuring out these at larger threat, it permits for extra centered and environment friendly use of sources, bettering the general high quality of affected person care and probably resulting in earlier analysis of clinically important illness. The event of this take a look at displays a rising development in the direction of customized drugs, the place diagnostic instruments are tailor-made to particular person threat profiles.
